Dan H Barouch, M.D., PhD.
Affiliations: | Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, MA, United States |
Google:
"Dan Barouch"Mean distance: (not calculated yet)
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blass E, Colarusso A, Aid M, et al. (2024) Early spatiotemporal evolution of the immune response elicited by adenovirus serotype 26 vector vaccination in mice. Biorxiv : the Preprint Server For Biology |
| Lasrado N, Rowe M, McMahan K, et al. (2024) SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity. Science Translational Medicine. 16: eadp8920 |
| Collier AY, McMahan K, Jacob-Dolan C, et al. (2024) Decline of Mpox Antibody Responses After Modified Vaccinia Ankara-Bavarian Nordic Vaccination. Jama |
| Vanshylla K, Tolboom J, Stephenson KE, et al. (2024) Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates. Npj Vaccines. 9: 179 |
| Collier AY, McMahan K, Jacob-Dolan C, et al. (2024) Rapid Decline of Mpox Antibody Responses Following MVA-BN Vaccination. Medrxiv : the Preprint Server For Health Sciences |
| Rowe M, Collier AY, Barouch DH. (2024) Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience. Vaccine. 42: 126306 |
| Kenny A, van Duijn J, Dintwe O, et al. (2024) Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. Ebiomedicine. 108: 105320 |
| Martinot AJ, Cox F, Abbink P, et al. (2024) Ad26.M.Env ZIKV vaccine protects pregnant rhesus macaques and fetuses against Zika virus infection. Npj Vaccines. 9: 157 |
| Nelson GW, van Duijn J, Yuki Y, et al. (2024) Prediction of differential Gag versus Env responses to a mosaic HIV-1 vaccine regimen by HLA class I alleles. Journal of Virology. e0028124 |
| Gray GE, Mngadi K, Lavreys L, et al. (2024) Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet. Infectious Diseases |